Status:
RECRUITING
AI as an Aid for Weekly Symptom Intake in Radiotherapy
Lead Sponsor:
jaide
Collaborating Sponsors:
National Cancer Institute, Brazil
Conditions:
Radiotherapy Side Effect
Pelvic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study investigates the use of artificial intelligence (AI) and large language models (LLMs) to enhance the efficiency and accuracy of weekly treatment consultations (OTVs) in radiotherapy. It hypo...
Detailed Description
This clinical trial is a comparative study designed to evaluate the accuracy and time efficiency of an AI-enabled symptom summary tool in comparison to traditional medical review methods in patients u...
Eligibility Criteria
Inclusion
- All patients undergoing radiotherapy in the pelvic region.
Exclusion
- Cases of pelvic reirradiation or operated cases.
Key Trial Info
Start Date :
July 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06525181
Start Date
July 22 2024
End Date
December 15 2024
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA
Rio de Janeiro, Brazil